A single-dose gene therapy has demonstrated significant reduction in bleeding episodes for adults with haemophilia B, potentially offering a long-term solution to this genetic disorder.
In a groundbreaking study published in Nature Communications [1], researchers at the Fred Hutchinson Cancer Center have reported encouraging findings from pre-clinical studies on an experimental gene therapy for genital and oral herpes infections caused by the herpes simplex virus (HSV).
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
